Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
Research from Kirby Institute shows three dose schedule of HPV vaccine protects vulnerable children with weakened immunity at least five years after vaccination. READ MORE